Biotech Stock News (PFE) (ANAC) (ADRO) (ADXS)

Pfizer (NYSE:PFE) On Monday May 16, 2016 Pfizer had announced that it would acquire Anacor Pharmaceuticals (NASDAQ:ANAC) for $5.2 billion. Translating the $5.2 billion amount to stock, would make it a buyout at $99.25 per share. When this deal was first announced, Anacor was trading in the mid 60’s level. Why exactly did Pfizer feel … Read more

Biotech Stock News (ONCE) (AAVL) (CLDN) (ADXS) (OPK) (PFE)

Spark Therapeutics (NASDAQ:ONCE) On October 5, 2015 shares of Spark Therapeutics ended the day up at least 25% after the company announced that it had achieved positive phase 3 results in patients with a rare form of blindness. This rare form of blindness stems from a mutation in the RPE65 gene of the eye which … Read more